Iris Wang
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- Pancreatic and Hepatic Oncology Research
-
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 5
-
- T-cell and B-cell Immunology 2
- Co-authors
- Ellen J. Spartz (3 shared papers)Ingunn M. Stromnes (3 shared papers)Adam L. Burrack (3 shared papers)Mirko K. Fillbrunn (1 shared paper)Zhihong Hu (2 shared papers)Antonia Ridolfi (1 shared paper)Amer Wahed (1 shared paper)Jinhee Park (1 shared paper)
- Journals
- Cancer Cell (2 papers)Frontiers in Immunology (1 paper)The Oncologist (1 paper)BMC Cancer (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Iris Wang
11 papers receiving 501 citations
Peers
Comparison fields: 5 of 47
- Oncology 226
- Cancer Research 59
- Health Informatics 8
- Genetics 64
- Immunology 42
Countries citing papers authored by Iris Wang
This map shows the geographic impact of Iris Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Wang more than expected).
Fields of papers citing papers by Iris Wang
This network shows the impact of papers produced by Iris Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Wang. The network helps show where Iris Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 162 | |
| 2 | 2022 | 89 | |
| 3 | 2019 | 73 | |
| 4 | 2024 | 52 | |
| 5 | 2022 | 44 | |
| 6 | 2018 | 41 | |
| 7 | 2021 | 28 | |
| 8 | 2022 | 13 | |
| 9 | 2022 | 9 | |
| 10 | 2025 | 2 | |
| 11 | 2020 | 1 | |
| 12 | 2025 | 0 |
About Iris Wang
Iris Wang is a scholar working on Oncology, Immunology, Molecular Biology, Hematology and Cancer Research, having authored 12 papers that have together received 514 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), T-cell and B-cell Immunology (2 papers), Acute Myeloid Leukemia Research (1 paper), Single-cell and spatial transcriptomics (1 paper), Gut microbiota and health (1 paper), BRCA gene mutations in cancer (1 paper), DNA Repair Mechanisms (1 paper) and PI3K/AKT/mTOR signaling in cancer (1 paper). The work is most often cited by research in Oncology (226 citations), Cancer Research (59 citations), Health Informatics (8 citations), Genetics (64 citations) and Immunology (42 citations). Iris Wang has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Ellen J. Spartz, Ingunn M. Stromnes, Adam L. Burrack, Mirko K. Fillbrunn, Zhihong Hu, Antonia Ridolfi, Amer Wahed, Jinhee Park, Hope S. Rugo and Fabrice André. Their work appears in journals such as Cancer Cell, Frontiers in Immunology, The Oncologist, BMC Cancer and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.